Clinical Utility of Positron Emission Tomography/Computed Tomography in the Evaluation of Suspected Recurrent Ovarian Cancer in the Setting of Normal CA-125 Levels

@article{Bhosale2010ClinicalUO,
  title={Clinical Utility of Positron Emission Tomography/Computed Tomography in the Evaluation of Suspected Recurrent Ovarian Cancer in the Setting of Normal CA-125 Levels},
  author={P. Bhosale and Silanath Peungjesada and W. Wei and C. Levenback and K. Schmeler and E. Rohren and H. Macapinlac and R. Iyer},
  journal={International Journal of Gynecologic Cancer},
  year={2010},
  volume={20},
  pages={936 - 944}
}
  • P. Bhosale, Silanath Peungjesada, +5 authors R. Iyer
  • Published 2010
  • Medicine
  • International Journal of Gynecologic Cancer
  • Objectives: This study was conducted to estimate the accuracy of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) as compared with contrast-enhanced CT (CECT) in detecting cancer in patients who have normal cancer antigen (CA)-125 (<35 U/dL) but are suspected of having a recurrent disease based on clinical symptoms. Methods: We retrospectively reviewed the records of patients who had undergone primary cytoreductive surgery and subsequently underwent CECT… CONTINUE READING
    50 Citations
    Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up
    • 11
    • PDF

    References

    SHOWING 1-10 OF 53 REFERENCES
    Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings
    • 92